Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult (Q80189855)
Jump to navigation
Jump to search
scientific article published on 11 December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult |
scientific article published on 11 December 2007 |
Statements
Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group (English)
Krystyna Zawilska
Agnieszka Wierzbowska
Jerzy Hołowiecki
Sebastian Giebel
Sebastian Grosicki
Tadeusz Robak
Janusz Kłoczko
Kazimierz Kuliczkowski
Aleksander B Skotnicki
Sławomira Kyrcz-Krzemień
Agata Wrzesień-Kuś
Beata Piatkowska-Jakubas
Agnieszka Pluta
Ewa Wawrzyniak
Barbara Cebula
Marek Kiełbiński
Polish Adult Leukemia Group
11 December 2007